marijuana stocks news

mCig, Inc. (MCIG)

 
Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Jan 31, 2015 Oct 31, 2014 Jul 31, 2014 Apr 30, 2014
Total Revenue 88   160   196   270  
Cost of Revenue 28 69 97 127
Gross Profit 61   91   98   143  
Operating Expenses
Research Development – – – –
Selling General and Administrative 803 868 1,153 238
Non Recurring – – – –
Others 2 2 2 2
Total Operating Expenses – – – –
Operating Income or Loss (744) (779) (1,057) (97)
Income from Continuing Operations
Total Other Income/Expenses Net – – – –
Earnings Before Interest And Taxes (744) (779) (1,057) (97)
Interest Expense – – – –
Income Before Tax (744) (779) (1,057) (97)
Income Tax Expense – – – –
Minority Interest – – – –
Net Income From Continuing Ops (744) (779) (1,057) (97)
Non-recurring Events
Discontinued Operations – – – –
Extraordinary Items – – – –
Effect Of Accounting Changes – – – –
Other Items – – – –
Net Income (744) (779) (1,057) (97)
Preferred Stock And Other Adjustments – – – –
Net Income Applicable To Common Shares (744) (779) (1,057) (97)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$PHOT Announces Relisting to OTCBB

GrowLife Announces Relisting to OTCBB GrowLife, Inc. (OTCBB: PHOT), one of the…

Aphria Inc. (APHQF) completes first medical cannabis shipment to Australia-based partner Althea

Aphria completes first medical cannabis shipment to Australia-based partner Althea Aphria Inc.…

$PLPL Enters Into Agreement to Supply Phytofare to United Kingdom

Plandai Biotechnology Enters Into Agreement to Supply Phytofare to United Kingdom Distributor…

GW Pharmaceuticals plc (GWPH) Completes Rolling New Drug Application Submission to U.S. Food and Drug Administration

GW Pharmaceuticals and its U.S. Subsidiary Greenwich Biosciences Completes Rolling New Drug…